Vivo Bio Tech Limited (BOM:511509)
India
· Delayed Price · Currency is INR 39.41
-0.84 (-2.09%)
At close: May 16, 2025
Vivo Bio Tech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 12.81 | 13.9 | 13.75 | 17.14 | 11.65 | Upgrade
|
| Cash & Short-Term Investments | 12.81 | 13.9 | 13.75 | 17.14 | 11.65 | Upgrade
|
| Cash Growth | -7.84% | 1.08% | -19.77% | 47.03% | 13.30% | Upgrade
|
| Accounts Receivable | 112.51 | 117.95 | 123.8 | 120.24 | 72.93 | Upgrade
|
| Other Receivables | - | 10.58 | 32.28 | 8.89 | - | Upgrade
|
| Receivables | 321.08 | 363.21 | 216.5 | 136.25 | 101.78 | Upgrade
|
| Inventory | 77.91 | 87.74 | 79.73 | 98.12 | 132.77 | Upgrade
|
| Other Current Assets | 7.57 | 7.48 | 7.94 | 8.81 | 24.66 | Upgrade
|
| Total Current Assets | 419.37 | 472.32 | 317.91 | 260.32 | 270.87 | Upgrade
|
| Property, Plant & Equipment | 772.24 | 814.65 | 799.62 | 824.13 | 410.35 | Upgrade
|
| Other Intangible Assets | 238.57 | 81.21 | 108.06 | 136.24 | 113.36 | Upgrade
|
| Long-Term Deferred Charges | - | 3.16 | 4.73 | 4.17 | 0.65 | Upgrade
|
| Other Long-Term Assets | 2.14 | 0 | 0 | - | - | Upgrade
|
| Total Assets | 1,432 | 1,371 | 1,230 | 1,225 | 795.23 | Upgrade
|
| Accounts Payable | 9.81 | 10.6 | 9.42 | 23.16 | 13.88 | Upgrade
|
| Accrued Expenses | - | 37.87 | 36.92 | 27.46 | 27.84 | Upgrade
|
| Short-Term Debt | 190.88 | 226.79 | 115.87 | 109.19 | 163.07 | Upgrade
|
| Current Portion of Long-Term Debt | - | 85.98 | 77.17 | 64.41 | - | Upgrade
|
| Current Income Taxes Payable | - | 17.91 | 10.31 | 7.59 | 13.58 | Upgrade
|
| Other Current Liabilities | 77.71 | -0 | 0 | - | - | Upgrade
|
| Total Current Liabilities | 278.4 | 379.15 | 249.69 | 231.81 | 218.37 | Upgrade
|
| Long-Term Debt | 349.37 | 417.87 | 430.92 | 500.78 | 146.5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 17.7 | 23.42 | 24.85 | 15.44 | 0.31 | Upgrade
|
| Other Long-Term Liabilities | 7.8 | 0 | -0 | 0 | - | Upgrade
|
| Total Liabilities | 653.27 | 827.34 | 711.6 | 753.57 | 369.96 | Upgrade
|
| Common Stock | 171.65 | 149.04 | 149.04 | 142.64 | 134.2 | Upgrade
|
| Additional Paid-In Capital | - | 149.58 | 149.58 | 128.13 | 105.2 | Upgrade
|
| Retained Earnings | - | 216.13 | 190.87 | 164.38 | 142.36 | Upgrade
|
| Comprehensive Income & Other | 607.4 | 29.25 | 29.25 | 36.15 | 43.51 | Upgrade
|
| Shareholders' Equity | 779.05 | 544 | 518.73 | 471.28 | 425.27 | Upgrade
|
| Total Liabilities & Equity | 1,432 | 1,371 | 1,230 | 1,225 | 795.23 | Upgrade
|
| Total Debt | 540.25 | 730.64 | 623.96 | 674.39 | 309.57 | Upgrade
|
| Net Cash (Debt) | -527.44 | -716.74 | -610.21 | -657.25 | -297.91 | Upgrade
|
| Net Cash Per Share | -34.47 | -42.97 | -41.16 | -46.40 | -21.97 | Upgrade
|
| Filing Date Shares Outstanding | 15.4 | 14.9 | 14.9 | 14.26 | 13.42 | Upgrade
|
| Total Common Shares Outstanding | 15.4 | 14.9 | 14.9 | 14.26 | 13.42 | Upgrade
|
| Working Capital | 140.96 | 93.17 | 68.22 | 28.51 | 52.5 | Upgrade
|
| Book Value Per Share | 50.58 | 36.50 | 34.81 | 33.04 | 31.69 | Upgrade
|
| Tangible Book Value | 540.48 | 462.79 | 410.67 | 335.05 | 311.91 | Upgrade
|
| Tangible Book Value Per Share | 35.09 | 31.05 | 27.56 | 23.49 | 23.24 | Upgrade
|
| Land | - | 228.8 | 228.8 | 228.8 | 26.99 | Upgrade
|
| Buildings | - | 174.89 | 174.89 | 174.89 | 31.66 | Upgrade
|
| Machinery | - | 751.87 | 747.18 | 717.51 | 604.69 | Upgrade
|
| Construction In Progress | - | 92.12 | 18.97 | 8.66 | 3.25 | Upgrade
|
Updated Jan 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.